Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-17-059310

President & CEO sold 83,334 shares at $23.57 ($1,964,182)

  • President & CEO acquired 83,334 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

ROBIN HOWARD W · President & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-11-01 Exercise or conversion : show line 1 in the form +83,334 $11.34 $945,008 235,838 D
2017-11-01 Sale : show line 2 in the form −83,334 $23.57 $1,964,182 152,504 D
Open-market sales · 83,334 sh · avg $23.57 · $1,964,182

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2017-11-01 Exercise or conversion : show line 3 in the form Stock Option −83,334 166,666 D
Loading xslF345X03/doc4.xml…